NCT05201547 Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05194735 Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05191212 Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer Status COMPLETED Phase NA
NCT05169437 Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Status TERMINATED Phase PHASE2
NCT05143970 A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05124743 HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors Status TERMINATED Phase N/A
NCT05123482 A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT05107739 A Study of DeTIL-0255 in Adults With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT05103683 First in Human Study of TORL-1-23 in Participants With Advanced Cancer Status RECRUITING Phase PHASE1
NCT05099978 Asian Multicenter Prospective Study of ctDNA Sequencing Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05082025 Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations Status TERMINATED Phase PHASE2
NCT05057013 A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05056259 Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients Status UNKNOWN Phase N/A
NCT05056077 Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05051722 Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer Status RECRUITING Phase N/A